Viewing Study NCT07342868


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-31 @ 12:22 AM
Study NCT ID: NCT07342868
Status: RECRUITING
Last Update Posted: 2026-02-04
First Post: 2025-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function
Sponsor: Aligos Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ALG-000184-207
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators